Company Filing History:
Years Active: 1980-1989
Title: The Innovative Contributions of Richard L. Wolgemuth
Introduction
Richard L. Wolgemuth is a notable inventor based in Plain City, Ohio. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer treatments. With a total of six patents to his name, his work has had a profound impact on medical science.
Latest Patents
Wolgemuth's latest patents include innovative pharmaceutical preparations of 4-demethoxy-N-trifluoroacetyl. This includes antineoplastic pharmaceutical preparations and a method for treating neoplastic conditions using 4-demethoxy-N-trifluoroacetyldaunomycin and 4-demethoxy-N-trifluoroacetyldoxorubicin. Additionally, he has developed 14-acyloxy-2'-halo-anthracycline anti-cancer antibiotics. These compounds are designed to inhibit malignant diseases and represent a significant advancement in cancer treatment.
Career Highlights
Throughout his career, Richard L. Wolgemuth has worked with reputable organizations such as Adria Laboratories Inc. and The Ohio State University. His experience in these institutions has allowed him to refine his research and contribute to groundbreaking pharmaceutical innovations.
Collaborations
Wolgemuth has collaborated with esteemed colleagues, including John P. Carter, Jr. and Derek Horton. These partnerships have facilitated the exchange of ideas and have been instrumental in advancing his research.
Conclusion
Richard L. Wolgemuth's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a significant inventor in the field. His patents and collaborations reflect a commitment to improving medical outcomes through innovative research.